Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-25 | New | $5,258,906 | $5,258,906 | Equity Only | 06b | SEC link |
| 2024-03-26 | New | $6,166,000 | $6,166,000 | Other | 06b | SEC link |
| 2023-06-16 | New | $8,389,479 | $8,389,479 | Equity Only | 06b | SEC link |
| 2021-02-23 | New | $200,000 | $200,000 | Other | 06b | SEC link |
| 2020-09-01 | New | $2,855,000 | $2,855,000 | Equity Only | 06b | SEC link |
| 2019-05-07 | Amended | $2,150,000 | $880,000 | Other | 06b | SEC link |
| 2019-03-25 | New | $1,270,000 | $1,270,000 | Other | 06b | SEC link |
| 2019-01-23 | New | $75,000 | $75,000 | Other | 06b | SEC link |
| 2018-08-21 | New | $450,000 | $450,000 | Other | 06b | SEC link |
| 2018-08-21 | Amended | $450,000 | $0 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Guilherme Cherman Perdig?O De Oliveira | Director |
| Guilherme Cherman Perdigao De Oliveira | Director, Executive |
| Anthony Matthew Chow | Director |
| Kelsey Moody | Director |
| Reason N/A | Director, Executive |
| Guilherme Cherman Perdigao De Oliveira | Director |